The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease
{{output}}
Introduction: Immunogenicity of biologic agents for inflammatory bowel disease (IBD) is a critical issue, especially for tumor necrosis factor (TNF) inhibitors, where anti-drug antibodies (ADAs) significantly impact drug clearanc... ...
